Full Spectrum Genetics is a privately-held protein analysis and engineering platform and product company.
May 2, 2012
Full Spectrum Genetics Receives Milestone Payment from Corporate Partner for Successfully Completing Therapeutic Protein Project
May 15, 2012
Full Spectrum Genetics Receives Milestone Payment from Corporate Partner for Successfully Completing Therapeutic Antibody Project
The Company’s MapEng™ platform enables the ultra-high throughput quantification of the effect on binding of every possible single amino acid substitution within a protein binding site. The MapEng™ platform provides a comprehensive analysis of protein structure/function relationships, with multiple applications for generating better therapeutics and diagnostics.